FMC CORPORATION OUTLOOK STATEMENT FOR 2013

ISSUED: July 30, 2013

Earnings Outlook* Full-year 2013 adjusted earnings of $3.72 to $3.87 per diluted share. Third quarter adjusted earnings of $0.75 to $0.85 per diluted share. Agricultural Solutions Full-year revenue up in the high-teens percent reflecting increased volumes due to strong market conditions and growth from new and recently introduced products, including new fungicides, as well as our direct market access initiatives in Asia and Latin America. Full-year segment earnings up in the mid- to high-teens percent driven by sales gains partially offset by increased SG&A and R&D spending to support growth. Third quarter segment earnings up low-teens percent reflecting solid start to Latin American season. Health and Nutrition Full-year revenue up mid-teens percent driven by higher volumes and growth from acquisitions. Full-year segment earnings up low-teens percent, with gains in core business segments and benefits from Epax acquisition partially offset by acquisition and manufacturing excellence costs. Third quarter segment earnings up low-single digits percent with solid growth in core segments tempered by acquisition and manufacturing excellence costs. Minerals Full-year revenue up low-single digits percent driven primarily by volumes and higher prices in soda ash in the second half of the year as well as Lithium operations improvements in the second half. Full-year segment earnings down nearly 20 percent, reflecting Lithium margin improvements offset by more conservative pace of export soda ash price recovery. Third quarter segment earnings down in the low-teens percent due to pace of export soda ash price improvement. Corporate and Other Financial Items*:

Interest expense Corporate and other Non-controlling interest D&A Capital additions and other investing activities Tax rate (before restructuring and other charges) Full Year Weighted Average Diluted Shares outstanding

Full-Year 2013 ~ $45 million ~ $85 million ~ $13 million ~$130 million ~$350 million ~26.0 percent ~136.1 million

* Reflecting the shift of FMC Peroxygens to discontinued operations, all items and comparisons to 2012 exclude FMC Peroxygens segment results. Below are quarterly adjusted earnings per diluted share for 2012 and the first two quarters of 2013: 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 $0.94 $0.89 $0.76 $0.78 $1.08 $0.93

Safe Harbor Statement under the Private Securities Act of 1995: Statements in this Outlook Statement that are forward-looking statements are subject to various risks and uncertainties concerning specific factors described in FMC Corporation's 2012 Form 10-K and other SEC filings. Such information contained herein represents management's best judgment as of the date hereof based on information currently available. FMC Corporation does not undertake any duty to update this information more than once a quarter and disclaims any legal obligation to the contrary. Historical information is not necessarily indicative of future performance.